Cargando…

Colorectal cancer treatment using bacteria: focus on molecular mechanisms

BACKGROUND: Colorectal cancer which is related to genetic and environmental risk factors, is among the most prevalent life-threatening cancers. Although several pathogenic bacteria are associated with colorectal cancer etiology, some others are considered as highly selective therapeutic agents in co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebrahimzadeh, Sara, Ahangari, Hossein, Soleimanian, Alireza, Hosseini, Kamran, Ebrahimi, Vida, Ghasemnejad, Tohid, Soofiyani, Saiedeh Razi, Tarhriz, Vahideh, Eyvazi, Shirin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287294/
https://www.ncbi.nlm.nih.gov/pubmed/34281519
http://dx.doi.org/10.1186/s12866-021-02274-3
_version_ 1783723886254227456
author Ebrahimzadeh, Sara
Ahangari, Hossein
Soleimanian, Alireza
Hosseini, Kamran
Ebrahimi, Vida
Ghasemnejad, Tohid
Soofiyani, Saiedeh Razi
Tarhriz, Vahideh
Eyvazi, Shirin
author_facet Ebrahimzadeh, Sara
Ahangari, Hossein
Soleimanian, Alireza
Hosseini, Kamran
Ebrahimi, Vida
Ghasemnejad, Tohid
Soofiyani, Saiedeh Razi
Tarhriz, Vahideh
Eyvazi, Shirin
author_sort Ebrahimzadeh, Sara
collection PubMed
description BACKGROUND: Colorectal cancer which is related to genetic and environmental risk factors, is among the most prevalent life-threatening cancers. Although several pathogenic bacteria are associated with colorectal cancer etiology, some others are considered as highly selective therapeutic agents in colorectal cancer. Nowadays, researchers are concentrating on bacteriotherapy as a novel effective therapeutic method with fewer or no side effects to pay the way of cancer therapy. The introduction of advanced and successful strategies in bacterial colorectal cancer therapy could be useful to identify new promising treatment strategies for colorectal cancer patients. MAIN TEXT: In this article, we scrutinized the beneficial effects of bacterial therapy in colorectal cancer amelioration focusing on different strategies to use a complete bacterial cell or bacterial-related biotherapeutics including toxins, bacteriocins, and other bacterial peptides and proteins. In addition, the utilization of bacteria as carriers for gene delivery or other known active ingredients in colorectal cancer therapy are reviewed and ultimately, the molecular mechanisms targeted by the bacterial treatment in the colorectal cancer tumors are detailed. CONCLUSIONS: Application of the bacterial instrument in cancer treatment is on its way through becoming a promising method of colorectal cancer targeted therapy with numerous successful studies and may someday be a practical strategy for cancer treatment, particularly colorectal cancer.
format Online
Article
Text
id pubmed-8287294
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82872942021-07-19 Colorectal cancer treatment using bacteria: focus on molecular mechanisms Ebrahimzadeh, Sara Ahangari, Hossein Soleimanian, Alireza Hosseini, Kamran Ebrahimi, Vida Ghasemnejad, Tohid Soofiyani, Saiedeh Razi Tarhriz, Vahideh Eyvazi, Shirin BMC Microbiol Review BACKGROUND: Colorectal cancer which is related to genetic and environmental risk factors, is among the most prevalent life-threatening cancers. Although several pathogenic bacteria are associated with colorectal cancer etiology, some others are considered as highly selective therapeutic agents in colorectal cancer. Nowadays, researchers are concentrating on bacteriotherapy as a novel effective therapeutic method with fewer or no side effects to pay the way of cancer therapy. The introduction of advanced and successful strategies in bacterial colorectal cancer therapy could be useful to identify new promising treatment strategies for colorectal cancer patients. MAIN TEXT: In this article, we scrutinized the beneficial effects of bacterial therapy in colorectal cancer amelioration focusing on different strategies to use a complete bacterial cell or bacterial-related biotherapeutics including toxins, bacteriocins, and other bacterial peptides and proteins. In addition, the utilization of bacteria as carriers for gene delivery or other known active ingredients in colorectal cancer therapy are reviewed and ultimately, the molecular mechanisms targeted by the bacterial treatment in the colorectal cancer tumors are detailed. CONCLUSIONS: Application of the bacterial instrument in cancer treatment is on its way through becoming a promising method of colorectal cancer targeted therapy with numerous successful studies and may someday be a practical strategy for cancer treatment, particularly colorectal cancer. BioMed Central 2021-07-19 /pmc/articles/PMC8287294/ /pubmed/34281519 http://dx.doi.org/10.1186/s12866-021-02274-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Ebrahimzadeh, Sara
Ahangari, Hossein
Soleimanian, Alireza
Hosseini, Kamran
Ebrahimi, Vida
Ghasemnejad, Tohid
Soofiyani, Saiedeh Razi
Tarhriz, Vahideh
Eyvazi, Shirin
Colorectal cancer treatment using bacteria: focus on molecular mechanisms
title Colorectal cancer treatment using bacteria: focus on molecular mechanisms
title_full Colorectal cancer treatment using bacteria: focus on molecular mechanisms
title_fullStr Colorectal cancer treatment using bacteria: focus on molecular mechanisms
title_full_unstemmed Colorectal cancer treatment using bacteria: focus on molecular mechanisms
title_short Colorectal cancer treatment using bacteria: focus on molecular mechanisms
title_sort colorectal cancer treatment using bacteria: focus on molecular mechanisms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287294/
https://www.ncbi.nlm.nih.gov/pubmed/34281519
http://dx.doi.org/10.1186/s12866-021-02274-3
work_keys_str_mv AT ebrahimzadehsara colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms
AT ahangarihossein colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms
AT soleimanianalireza colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms
AT hosseinikamran colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms
AT ebrahimivida colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms
AT ghasemnejadtohid colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms
AT soofiyanisaiedehrazi colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms
AT tarhrizvahideh colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms
AT eyvazishirin colorectalcancertreatmentusingbacteriafocusonmolecularmechanisms